JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

EndNote Style
Index
Letter to the Editor
Letter: Evaluation of the Frequency of Hepatitis B Virus Reactivation and the Importance of Hepatitis B Prophylaxis in Hematology Patients Receiving Immunosuppressive Therapy: A Single-Center Study
We are writing to express our appreciation for the recent publication in the Journal of Current Hematology & Oncology Research titled “Evaluation of the frequency of hepatitis B virus reactivation and the importance of hepatitis B prophylaxis in hematology patients receiving immunosuppressive therapy: a single-center study” by Doğan et al. As gastroenterologists, we find this work particularly valuable as it highlights the importance of hepatitis B virus (HBV) prophylaxis in patients undergoing immunosuppressive therapy, which is a vital concern in gastroenterology practice as well


1. Doğan A, Ekinci Ö, Yıldırım Doğan N, et al. Evaluation of the frequency of hepatitis B virus reactivation and the importance of hepatitis B prophylaxis in hematology patients receiving immunosuppressive therapy: a single-center study. J Curr Hematol Oncol Res. 2023;1(4):83-87. doi:10.51271/JCHOR-0019
2. Wang B, Mufti G, Agarwal K. Reactivation of hepatitis B virus infection in patients with hematologic disorders. Haematologica. 2019;104(3):435-443. doi:10.3324/haematol.2018.210252
3. Evens AM, Jovanovic BD, Su YC, et al. Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports.Ann Oncol.2011;22(5):1170-1180. doi: 10.1093/annonc/mdq583
4. Ayaz ÇM, Başpınar B, Güner R. Clinical and laboratory characteristics of patients with hepatitis B patients with atypical serologic profiles.Viral Hepat J.2022;28(3):94-99. doi:10.4274/vhd.galenos.2022.2022-6-2
Volume 3, Issue 1, 2025
Page : 20-21
_Footer